Skip to main content

Advertisement

Log in

Inhibition of macrophage migration by C. botulinum exoenzyme C3

  • Original Article
  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Abstract

C3-like exoenzymes are produced by various microorganism including Clostridium botulinum (C3bot), Bacillus cereus and Staphylococcus aureus. C3bot is the prototype of C3-like exoenzymes that specifically ADP-ribosylates and thereby inactivates Rho(A/B/C). C3-like exoenzymes are not yet regarded as virulence factors, as the lack of cell entry domains results in a poor accessibility of the C3-like exoenzymes to cells. In this study, the sensitivity of various cell lines to C3bot has been reinvestigated. Primary monocytes as well as cultured macrophage-like cells including J774A.1 cells and RAW macrophages exhibit a tenfold higher sensitivity to C3bot than fibroblasts and epithelial cells. RhoA ADP-ribosylation by C3bot resulted in the formation of pronounced bipolar protrusions based on defective tail retraction. The formation of bipolar protrusion resulted in inhibited macrophage migration. These findings suggested that macrophages appear to be target cells of C3bot. Migration of macrophage is a prerequiste for their recruitment to the site of pathogen invasion or tissue damage. Inhibition of macrophage migration likely preserves the survival of C3-producing microorganisms. The observations of this study reinforce the paradigm of a role of C3-like exoenzymes as virulence factors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Abbreviations

C3bot:

Exoenzyme C3 from C. botulinum

IL-2:

Interleukin-2

PI3K:

Phosphatidylinositide 3′-OH kinase

TcdB:

Toxin B from the C. difficile strain VPI10463

TcdBF:

Toxin B from the C. difficile serotype F strain 1470.

References

  • Amano M, Nakayama M, Kaibuchi K (2010) Rho-kinase/ROCK: a key regulator of the cytoskeleton and cell polarity. Cytoskeleton (Hoboken ) 67:545–554

    CAS  Google Scholar 

  • Fahrer J, Kuban J, Heine K, Rupps G, Kaiser E, Felder E, Benz R, Barth H (2010) Selective and specific internalization of clostridial C3 ADP-ribosyltransferases into macrophages and monocytes. Cell Microbiol 12:233–247

    Article  PubMed  CAS  Google Scholar 

  • Geback T, Schulz MM, Koumoutsakos P, Detmar M (2009) TScratch: a novel and simple software tool for automated analysis of monolayer wound healing assays. Biotechniques 46:265–274

    PubMed  CAS  Google Scholar 

  • Genth H, Gerhard R, Maeda A, Amano M, Kaibuchi K, Aktories K, Just I (2003a) Entrapment of Rho ADP-ribosylated by Clostridium botulinum C3 exoenzyme in the Rho-guanine nucleotide dissociation inhibitor-1 complex. J Biol Chem 278:28523–28527

    Article  PubMed  CAS  Google Scholar 

  • Genth H, Schmidt M, Gerhard R, Aktories K, Just I (2003b) Activation of phospholipase D1 by ADP-ribosylated RhoA. Biochem Biophys Res Commun 302:127–132

    Article  PubMed  CAS  Google Scholar 

  • Hanley PJ, Xu Y, Kronlage M, Grobe K, Schon P, Song J, Sorokin L, Schwab A, Bahler M (2010) Motorized RhoGAP myosin IXb (Myo9b) controls cell shape and motility. Proc Natl Acad Sci USA 107:12145–12150

    Article  PubMed  CAS  Google Scholar 

  • Holtje M, Djalali S, Hofmann F, Munster-Wandowski A, Hendrix S, Boato F, Dreger SC, Grosse G, Henneberger C, Grantyn R, Just I, hnert-Hilger G (2009) A 29-amino acid fragment of Clostridium botulinum C3 protein enhances neuronal outgrowth, connectivity, and reinnervation. FASEB J 23:1115–1126

    Article  PubMed  Google Scholar 

  • Huelsenbeck J, Dreger S, Gerhard R, Barth H, Just I, Genth H (2007a) Difference in the cytotoxic effects of toxin B from Clostridium difficile strain VPI 10463 and toxin B from variant Clostridium difficile strain 1470. Infect Immun 75:801–809

    Article  PubMed  CAS  Google Scholar 

  • Huelsenbeck J, Dreger SC, Gerhard R, Fritz G, Just I, Genth H (2007b) Upregulation of the immediate early gene product RhoB by exoenzyme C3 from Clostridium limosum and toxin B from Clostridium difficile. Biochemistry 46:4923–4931

    Article  PubMed  CAS  Google Scholar 

  • Huelsenbeck SC, May M, Schmidt G, Genth H (2009) Inhibition of cytokinesis by Clostridium difficile toxin B and cytotoxic necrotizing factors—reinforcing the critical role of RhoA in cytokinesis. Cell Motil Cytoskelet 66:967–975

    Article  CAS  Google Scholar 

  • Just I, Huelsenbeck SC, Genth H (2010) Clostridium botulinum C3 exoenzyme: rho-inactivating tool in cell biology and a neurotrophic agent. Open Toxinol J 3:19–23

    Article  CAS  Google Scholar 

  • Just I, Rohrbeck A, Huelsenbeck SC, Hoeltje M (2011) Therapeutic effects of Clostridium botulinum C3 exoenzyme. Naunyn Schmiedebergs Arch Pharmacol 383:247–252

    Article  PubMed  CAS  Google Scholar 

  • Kobayashi M, Azuma E, Ido M, Hirayama M, Jiang Q, Iwamoto S, Kumamoto T, Yamamoto H, Sakurai M, Komada Y (2001) A pivotal role of Rho GTPase in the regulation of morphology and function of dendritic cells. J Immunol 167:3585–3591

    PubMed  CAS  Google Scholar 

  • Park J, Kim JS, Jung KC, Lee HJ, Kim JI, Kim J, Lee JY, Park JB, Choi SY (2003) Exoenzyme Tat-C3 inhibits association of zymosan particles, phagocytosis, adhesion, and complement binding in macrophage cells. Mol Cells 16:216–223

    PubMed  CAS  Google Scholar 

  • Ridley AJ (2011) Life at the leading edge. Cell 145:1012–1022

    Article  PubMed  CAS  Google Scholar 

  • Savina A, Amigorena S (2007) Phagocytosis and antigen presentation in dendritic cells. Immunol Rev 219:143–156

    Article  PubMed  CAS  Google Scholar 

  • Siddiqui AR, Bernstein JM (2010) Chronic wound infection: facts and controversies. Clin Dermatol 28:519–526

    Article  PubMed  Google Scholar 

  • Tomar A, Schlaepfer DD (2009) Focal adhesion kinase: switching between GAPs and GEFs in the regulation of cell motility. Curr Opin Cell Biol 21:676–683

    Article  PubMed  CAS  Google Scholar 

  • Vega FM, Fruhwirth G, Ng T, Ridley AJ (2011) RhoA and RhoC have distinct roles in migration and invasion by acting through different targets. J Cell Biol 193:655–665

    Article  PubMed  CAS  Google Scholar 

  • Vogelsgesang M, Pautsch A, Aktories K (2007) C3 exoenzymes, novel insights into structure and action of Rho-ADP-ribosylating toxins. Naunyn Schmiedebergs Arch Pharmacol 374:347–360

    Article  PubMed  CAS  Google Scholar 

  • Wheeler AP, Ridley AJ (2007) RhoB affects macrophage adhesion, integrin expression and migration. Exp Cell Res 313:3505–3516

    Article  PubMed  CAS  Google Scholar 

  • Wilde C, Chhatwal GS, Schmalzing G, Aktories K, Just I (2001) A novel C3-like ADP-ribosyltransferase from Staphylococcus aureus modifying RhoE and Rnd3. J Biol Chem 276:9537–9542

    Article  PubMed  CAS  Google Scholar 

  • Worthylake RA, Lemoine S, Watson JM, Burridge K (2001) RhoA is required for monocyte tail retraction during transendothelial migration. J Cell Biol 154:147–160

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by Deutsche Forschungsgemeinschaft (project JU 231/5-1).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Harald Genth.

Electronic supplementary material

Below is the link to the electronic supplementary material.

J774A.1 macrophage motility was analysed using time lapse microscopy. Images were acquired by time lapse microscopy (DMI6000; Leica) every 10 min for 24 h (MPG 2,582 kb)

J774A.1 macrophages were treated with C3bot (300 nM). Cell motility was analysed using time lapse microscopy. Images were acquired by time lapse microscopy (DMI6000; Leica) every 10 min for 24 h (MPG 2,582 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rotsch, J., Rohrbeck, A., May, M. et al. Inhibition of macrophage migration by C. botulinum exoenzyme C3. Naunyn-Schmiedeberg's Arch Pharmacol 385, 883–890 (2012). https://doi.org/10.1007/s00210-012-0764-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00210-012-0764-9

Keywords

Navigation